Today: 30 April 2026
Why Walmart stock slipped after tariff jitters hit retailers — and what investors watch next
21 January 2026
2 mins read

Why Walmart stock slipped after tariff jitters hit retailers — and what investors watch next

New York, Jan 20, 2026, 17:36 EST — After-hours

  • Walmart shares slipped roughly 0.8% in late trading following a choppy session.
  • New tariff threats involving Greenland hit retail stocks and dented overall risk appetite.
  • All eyes are on Walmart’s Feb. 19 earnings, which could shed light on pricing trends and consumer demand.

Walmart Inc (WMT) shares dropped roughly 0.8% to $118.71 in after-hours trading Tuesday, hit by tariff concerns and a steep selloff on Wall Street weighing on retailers. The stock swung between $117.62 and $121.61 on a volume near 45 million shares.

Investors dumped risk after U.S. President Donald Trump threatened new tariffs on imports from eight European countries over a dispute involving Greenland. The S&P 500 dropped 2.06%, the Nasdaq lost 2.39%, and the Dow fell 1.76%, Reuters reported. The Cboe Volatility Index (VIX), which tracks expected stock swings, closed at its highest point since late November. Jamie Cox, managing partner at Harris Financial Group, told Reuters, “I’m not at the point yet” where the tariff dispute will spark a broader selloff. Reuters

Big retailers face a clear concern: tariffs can quickly raise import costs, sparking a battle over who foots the bill. Amazon CEO Andy Jassy noted the company is beginning “to see some of the tariffs creep into some prices” as earlier stockpiles dwindle. Some sellers are passing those costs on, while others are absorbing them to keep demand steady. Reuters

Walmart’s massive scale and commitment to “everyday low prices” attract bargain-hunting shoppers during tough times, but that strategy leaves slim margins if costs climb and rivals keep pressure on. Investors are closely tracking whether retailers can maintain prices without sacrificing profits.

Walmart is rolling out a “Premium Musical Instrument Shop” on its Marketplace, featuring top-tier brands like Fender, Roland, Boss, and Zildjian. The move marks a deeper push into curated, higher-end online categories. “We’re thrilled to bring some of the world’s most legendary music brands to Walmart Marketplace,” said Manish Joneja, senior vice president for Walmart Marketplace and Walmart Fulfillment Services. Walmart News

On Tuesday, Walmart joined the Nasdaq-100, the index tracking 100 of the largest non-financial firms on Nasdaq. Nasdaq announced that Walmart took AstraZeneca’s spot in the benchmark before the market opened Tuesday. This swap could affect fund flows for those tracking the index.

Walmart’s fiscal fourth-quarter earnings will drop on Feb. 19, according to its investor site. The company plans to release materials early that day, followed by a conference call before the U.S. market opens.

The tariff angle remains the wildcard. Should the levies kick in and expand, retailers might see prices climb while shopper activity stays flat — a tough combo that could drag down unit sales, promotions, and profit margins per basket.

Traders will be watching closely in the coming session and throughout the week for sharper signals on when and how the tariff plan might roll out, along with any hints of retaliation. Meanwhile, positioning is ramping up ahead of Walmart’s Feb. 19 earnings, with investors looking for insight into pricing strength, foot traffic, and the overall condition of the U.S. consumer.

Stock Market Today

  • Merck Reports Q1 Loss Beats Revenue Estimates, Shares Rise
    April 30, 2026, 9:21 AM EDT. Merck (MRK) posted a Q1 loss of $1.28 per share, beating the Zacks estimate loss of $1.51, narrowing from $2.22 profit a year ago. Revenue rose to $16.29 billion, surpassing estimates by 2.44% and increasing from $15.53 billion last year. The results marked Merck's fourth consecutive quarter exceeding earnings per share (EPS) forecasts. Despite current mixed earnings revisions, the stock holds a Zacks Rank #3 (Hold), suggesting performance in line with the market. Merck shares have gained 5.4% year-to-date versus the S&P 500's 4.2% rise. The Large Cap Pharmaceuticals sector ranks in the bottom 32% of Zacks industries, which may influence Merck's stock outlook. Investors await further guidance from management and upcoming earnings estimate revisions to gauge future share movement.

Latest article

US Dollar Drops as GDP Miss and Core PCE Jump Cloud Fed Cut Bets

US Dollar Drops as GDP Miss and Core PCE Jump Cloud Fed Cut Bets

30 April 2026
The U.S. dollar fell Thursday after first-quarter GDP growth missed forecasts and core inflation accelerated, complicating the Federal Reserve’s rate outlook. The Dollar Index dropped 0.59% to 98.33, with the dollar hitting session lows against the yen after Japanese officials hinted at intervention. The Fed held rates steady Wednesday but showed division over future cuts. U.S. GDP grew at a 2.0% annualized rate, while core PCE inflation jumped to 4.3%.
QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps
Previous Story

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps

Goldman Sachs stock drops after-hours as credit-card cap deadline hits banks; Qatar $25B tie-up in focus
Next Story

Goldman Sachs stock drops after-hours as credit-card cap deadline hits banks; Qatar $25B tie-up in focus

Go toTop